This screening test measures how well blood flows through your heart. It may be used to diagnose coronary artery disease or to assess damage caused by a heart attack. Share on Pinterest JazzIRT/Getty ...
Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results